// App-Quantinova.ai

PB1005 : Preclinical safety and toxicokinetics of VMX-C001 – an intravenous bypassing agent for factor Xa inhibitors

Researchers

Presenter

  • D. Verhoef

Principal Investigators

  • T. Gomes

  • G. Short

Medical Centers

  • 1VarmX, Leiden, The Netherlands. 2Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands., Leiden, Zuid-Holland, Netherlands

  • VarmX, Leiden, The Netherlands, Leiden, Zuid-Holland, Netherlands

  • VarmX, Leiden, The Netherlands., Cambridge, England, United Kingdom

Locations

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved